{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T20:59:35Z","timestamp":1789419575032,"version":"build-2803163510"},"reference-count":31,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T00:00:00Z","timestamp":1762905600000},"content-version":"vor","delay-in-days":1030,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2023,1,17]],"date-time":"2023-01-17T00:00:00Z","timestamp":1673913600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,4,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>The Iron Intravenous Therapy in Reducing the burden of Severe Arrhythmias in HFrEF (RESAFE-HF) registry study aims to provide real-word evidence on the impact of intravenous ferric carboxymaltose (FCM) on the arrhythmic burden of patients with heart failure with reduced ejection fraction (HFrEF), iron deficiency (ID), and implanted cardiac implantable electronic devices (CIEDs).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and results<\/jats:title>\n                    <jats:p>The RESAFE-HF (NCT04974021) study was designed as a prospective, single-centre, and open-label registry study with baseline, 3, 6, and 12 month visits. Adult patients with HFrEF and CIEDs scheduled to receive IV FCM as treatment for ID as part of clinical practice were eligible to participate. The primary endpoint is the composite iron-related endpoint of haemoglobin \u2265 12 g\/dL, ferritin \u2265 50 ng\/L, and transferrin saturation &amp;gt; 20%. Secondary endpoints include unplanned HF-related hospitalizations, ventricular tachyarrhythmias detected by CIEDs and Holter monitors, echocardiographic markers, functional status (VO2 max and 6 min walk test), blood biomarkers, and quality of life. In total, 106 patients with a median age of 72 years (14.4) were included. The majority were male (84.9%), whereas 92.5% of patients were categorized to New York Heart Association II\/III. Patients' arrhythmic burden prior to FCM administration was significant\u201419 patients (17.9%) received appropriate CIED therapy for termination of ventricular tachyarrhythmia in the preceding 12 months, and 75.5% of patients have frequent, repetitive multiform premature ventricular contractions.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The RESAFE-HF trial is expected to provide evidence on the effect of treating ID with FCM in HFrEF based on real-world data. Special focus will be given on the arrhythmic burden post-FCM administration.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1002\/ehf2.14276","type":"journal-article","created":{"date-parts":[[2023,1,17]],"date-time":"2023-01-17T03:40:49Z","timestamp":1673926849000},"page":"1184-1192","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Iron Therapy and Severe Arrhythmias in HFrEF: Rationale, Study Design, and Baseline Results of the RESAFE-HF Trial"],"prefix":"10.1093","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1132-9835","authenticated-orcid":false,"given":"Constantinos","family":"Bakogiannis","sequence":"first","affiliation":[{"name":"Third Cardiology Department, School of Medicine, Hippokration General Hospital, Aristotle University of Thessaloniki , Thessaloniki ,","place":["Greece"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0266-302X","authenticated-orcid":false,"given":"Dimitrios","family":"Mouselimis","sequence":"additional","affiliation":[{"name":"Third Cardiology Department, School of Medicine, Hippokration General Hospital, Aristotle University of Thessaloniki , Thessaloniki ,","place":["Greece"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2883-2688","authenticated-orcid":false,"given":"Anastasios","family":"Tsarouchas","sequence":"additional","affiliation":[{"name":"Third Cardiology Department, School of Medicine, Hippokration General Hospital, Aristotle University of Thessaloniki , Thessaloniki ,","place":["Greece"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christodoulos E.","family":"Papadopoulos","sequence":"additional","affiliation":[{"name":"Third Cardiology Department, School of Medicine, Hippokration General Hospital, Aristotle University of Thessaloniki , Thessaloniki ,","place":["Greece"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Efstratios K.","family":"Theofillogiannakos","sequence":"additional","affiliation":[{"name":"Third Cardiology Department, School of Medicine, Hippokration General Hospital, Aristotle University of Thessaloniki , Thessaloniki ,","place":["Greece"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elmira","family":"Lechat","sequence":"additional","affiliation":[{"name":"Vifor Pharma Management Ltd. , Glattbrugg ,","place":["Switzerland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonios P.","family":"Antoniadis","sequence":"additional","affiliation":[{"name":"Third Cardiology Department, School of Medicine, Hippokration General Hospital, Aristotle University of Thessaloniki , Thessaloniki ,","place":["Greece"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Efstathios D.","family":"Pagourelias","sequence":"additional","affiliation":[{"name":"Third Cardiology Department, School of Medicine, Hippokration General Hospital, Aristotle University of Thessaloniki , Thessaloniki ,","place":["Greece"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ioannis","family":"Kelemanis","sequence":"additional","affiliation":[{"name":"Third Cardiology Department, School of Medicine, Hippokration General Hospital, Aristotle University of Thessaloniki , Thessaloniki ,","place":["Greece"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stergios","family":"Tzikas","sequence":"additional","affiliation":[{"name":"Third Cardiology Department, School of Medicine, Hippokration General Hospital, Aristotle University of Thessaloniki , Thessaloniki ,","place":["Greece"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolaos","family":"Fragakis","sequence":"additional","affiliation":[{"name":"Third Cardiology Department, School of Medicine, Hippokration General Hospital, Aristotle University of Thessaloniki , Thessaloniki ,","place":["Greece"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgios K.","family":"Efthimiadis","sequence":"additional","affiliation":[{"name":"First Cardiology Department, School of Medicine, AHEPA University Hospital, Aristotle University of Thessaloniki , Thessaloniki ,","place":["Greece"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theodoros D.","family":"Karamitsos","sequence":"additional","affiliation":[{"name":"First Cardiology Department, School of Medicine, AHEPA University Hospital, Aristotle University of Thessaloniki , Thessaloniki ,","place":["Greece"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Doumas","sequence":"additional","affiliation":[{"name":"Second Propaedeutics Department of Internal Medicine, Hippokration General Hospital, Aristotle University of Thessaloniki , Thessaloniki ,","place":["Greece"]},{"name":"Georgetown University and VAMC and George Washington University , Washington, DC ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vassilios P.","family":"Vassilikos","sequence":"additional","affiliation":[{"name":"Third Cardiology Department, School of Medicine, Hippokration General Hospital, Aristotle University of Thessaloniki , Thessaloniki ,","place":["Greece"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2023,1,17]]},"reference":[{"key":"2026012114112336800_ehf214276-bib-0001","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1002\/ejhf.483","article-title":"Epidemiology of heart failure: the prevalence of heart failure and ventricular dysfunction in older adults over time. A systematic review","volume":"18","author":"van Riet","year":"2016","journal-title":"Eur J Heart Fail"},{"key":"2026012114112336800_ehf214276-bib-0002","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/s12872-018-0815-3","article-title":"Cost-of-illness studies in heart failure: a systematic review 2004\u20132016","volume":"18","author":"Lesyuk","year":"2018","journal-title":"BMC Cardiovasc Disord"},{"key":"2026012114112336800_ehf214276-bib-0003","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1007\/s10741-019-09890-2","article-title":"Quality of life of chronic heart failure patients: a systematic review and meta-analysis","volume":"25","author":"Moradi","year":"2020","journal-title":"Heart Fail Rev"},{"key":"2026012114112336800_ehf214276-bib-0004","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1002\/ejhf.1858","article-title":"Epidemiology of heart failure","volume":"22","author":"Groenewegen","year":"2020","journal-title":"Eur J Heart Fail"},{"key":"2026012114112336800_ehf214276-bib-0005","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.hlc.2018.09.011","article-title":"Current device therapies for sudden cardiac death prevention\u2014the ICD, subcutaneous ICD and wearable ICD","volume":"28","author":"Chieng","year":"2019","journal-title":"Heart Lung Circ"},{"key":"2026012114112336800_ehf214276-bib-0006","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1093\/eurheartj\/ehz553","article-title":"What causes sudden death in patients with chronic heart failure and a reduced ejection fraction?","volume":"41","author":"Packer","year":"2020","journal-title":"Eur Heart J"},{"key":"2026012114112336800_ehf214276-bib-0007","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.ijcard.2015.11.178","article-title":"The impact of iron deficiency and anaemia on exercise capacity and outcomes in patients with chronic heart failure. Results from the Studies Investigating Co-morbidities Aggravating Heart Failure","volume":"205","author":"Ebner","year":"2016","journal-title":"Int J Cardiol"},{"key":"2026012114112336800_ehf214276-bib-0008","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1002\/ehf2.13850","article-title":"Iron deficiency in heart failure patients: the French CARENFER prospective study","volume":"9","author":"Cohen-Solal","year":"2022","journal-title":"ESC Hear Fail"},{"key":"2026012114112336800_ehf214276-bib-0009","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1093\/eurheartj\/ehq158","article-title":"Iron deficiency: an ominous sign in patients with systolic chronic heart failure","volume":"31","author":"Jankowska","year":"2010","journal-title":"Eur Heart J"},{"key":"2026012114112336800_ehf214276-bib-0010","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.jacc.2007.09.036","article-title":"Effect of intravenous iron sucrose on exercise tolerance in anemic and nonanemic patients with symptomatic chronic heart failure and iron deficiency","volume":"51","author":"Okonko","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"2026012114112336800_ehf214276-bib-0011","doi-asserted-by":"crossref","first-page":"2436","DOI":"10.1056\/NEJMoa0908355","article-title":"Ferric carboxymaltose in patients with heart failure and iron deficiency","volume":"361","author":"Anker","year":"2009","journal-title":"N Engl J Med"},{"key":"2026012114112336800_ehf214276-bib-0012","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1093\/eurheartj\/ehu385","article-title":"Beneficial effects of long-term intravenous iron therapy with ferric carboxymaltose in patients with symptomatic heart failure and iron deficiency","volume":"36","author":"Ponikowski","year":"2015","journal-title":"Eur Heart J"},{"key":"2026012114112336800_ehf214276-bib-0013","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1161\/CIRCULATIONAHA.117.027497","article-title":"Effect of ferric carboxymaltose on exercise capacity in patients with chronic heart failure and iron deficiency","volume":"136","author":"van Veldhuisen","year":"2017","journal-title":"Circulation"},{"key":"2026012114112336800_ehf214276-bib-0014","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1093\/eurheartj\/ehw128","article-title":"2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"37","author":"Ponikowski","year":"2016","journal-title":"Eur Heart J"},{"key":"2026012114112336800_ehf214276-bib-0015","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","article-title":"2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"42","author":"McDonagh","year":"2021","journal-title":"Eur Heart J"},{"key":"2026012114112336800_ehf214276-bib-0016","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1002\/ejhf.640","article-title":"Myocardial iron content and mitochondrial function in human heart failure: a direct tissue analysis","volume":"19","author":"Melenovsky","year":"2017","journal-title":"Eur J Heart Fail"},{"key":"2026012114112336800_ehf214276-bib-0017","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.jacc.2011.01.059","article-title":"Myocardial and systemic iron depletion in heart failure","volume":"58","author":"Maeder","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"2026012114112336800_ehf214276-bib-0018","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2016\/9656078","article-title":"Cellular and molecular mechanisms of arrhythmia by oxidative stress","volume":"2016","author":"Sovari","year":"2016","journal-title":"Cardiol Res Pract"},{"key":"2026012114112336800_ehf214276-bib-0019","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s10741-019-09815-z","article-title":"Iron deficiency as therapeutic target in heart failure: a translational approach","volume":"25","author":"Bakogiannis","year":"2019","journal-title":"Heart Fail Rev"},{"key":"2026012114112336800_ehf214276-bib-0020","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.celrep.2015.09.023","article-title":"Lethal cardiomyopathy in mice lacking transferrin receptor in the heart","volume":"13","author":"Xu","year":"2015","journal-title":"Cell Rep"},{"key":"2026012114112336800_ehf214276-bib-0021","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1093\/europace\/eur342","article-title":"Ventricular automaticity as a predictor of sudden death in ischaemic heart disease","volume":"14","author":"Bastiaenen","year":"2012","journal-title":"Europace"},{"key":"2026012114112336800_ehf214276-bib-0022","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1046\/j.1440-1843.2001.00356.x","article-title":"Using baseline respiratory function data to optimize cycle exercise test duration","volume":"6","author":"Pretto","year":"2001","journal-title":"Respirology"},{"key":"2026012114112336800_ehf214276-bib-0023","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1161\/CIRCHEARTFAILURE.111.965186","article-title":"Modest increase in peak VO2 is related to better clinical outcomes in chronic heart failure patients","volume":"5","author":"Swank","year":"2012","journal-title":"Circ Heart Fail"},{"key":"2026012114112336800_ehf214276-bib-0024","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.115.002962","article-title":"Changes in left ventricular ejection fraction predict survival and hospitalization in heart failure with reduced ejection fraction","volume":"9","author":"Breathett","year":"2016","journal-title":"Circ Heart Fail"},{"key":"2026012114112336800_ehf214276-bib-0025","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1002\/ejhf.1536","article-title":"Evaluation of the effect of sodium\u2013glucose co-transporter 2 inhibition with empagliflozin on morbidity and mortality of patients with chronic heart failure and a reduced ejection fraction: rationale for and design of the EMPEROR-Reduced trial","volume":"21","author":"Packer","year":"2019","journal-title":"Eur J Heart Fail"},{"key":"2026012114112336800_ehf214276-bib-0026","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1002\/ejhf.813","article-title":"Epidemiology and one-year outcomes in patients with chronic heart failure and preserved, mid-range and reduced ejection fraction: an analysis of the ESC Heart Failure Long-Term Registry","volume":"19","author":"Chioncel","year":"2017","journal-title":"Eur J Heart Fail"},{"key":"2026012114112336800_ehf214276-bib-0027","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1002\/ejhf.823","article-title":"Effects of ferric carboxymaltose on hospitalisations and mortality rates in iron-deficient heart failure patients: an individual patient data meta-analysis","volume":"20","author":"Anker","year":"2018","journal-title":"Eur J Heart Fail"},{"key":"2026012114112336800_ehf214276-bib-0028","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.tcm.2016.03.012","article-title":"Remote monitoring of cardiac implantable electronic devices (CIED)","volume":"26","author":"Zeitler","year":"2016","journal-title":"Trends Cardiovasc Med"},{"key":"2026012114112336800_ehf214276-bib-0029","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1111\/j.1540-8167.2006.00545.x","article-title":"Management of far-field R wave sensing for the avoidance of inappropriate mode switch in dual chamber pacemakers: results of the FFS-test study","volume":"17","author":"Kolb","year":"2006","journal-title":"J Cardiovasc Electrophysiol"},{"key":"2026012114112336800_ehf214276-bib-0030","first-page":"34","article-title":"Comparative evaluation of the results of Holter monitoring and programmed ventricular stimulation in patients with ischemic heart disease","volume":"33","author":"Dabrowski","year":"1990","journal-title":"Kardiol Pol"},{"key":"2026012114112336800_ehf214276-bib-0031","doi-asserted-by":"crossref","first-page":"e33","DOI":"10.2459\/JCM.0000000000001263","article-title":"Myocardial iron content by T2 Star cardiac magnetic resonance and serum markers of iron metabolism in patients with heart failure","volume":"23","author":"Pereira","year":"2022","journal-title":"J Cardiovasc Med (Hagerstown)"}],"container-title":["ESC Heart Failure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/ehf2.14276","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/ehf2.14276","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/eschf\/article-pdf\/10\/2\/1184\/65051422\/eschf_10_2_1184.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eschf\/article-pdf\/10\/2\/1184\/65051422\/eschf_10_2_1184.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T19:12:42Z","timestamp":1769022762000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eschf\/article\/10\/2\/1184\/8304881"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,17]]},"references-count":31,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2023,1,17]]},"published-print":{"date-parts":[[2023,4,1]]}},"URL":"https:\/\/doi.org\/10.1002\/ehf2.14276","relation":{},"ISSN":["2055-5822"],"issn-type":[{"value":"2055-5822","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,4]]},"published":{"date-parts":[[2023,1,17]]},"assertion":[{"value":"2022-03-25","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-12-15","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-01-17","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}